Last Updated: 18/08/2025
Resistance to artemisinin, the first-line drug that first appeared in Africa Malaria: Elucidation of the epidemic mechanism
Objectives
*Original title and abstract were machine translated from Japanese.
To elucidate the epidemic mechanism of artemisinin resistance and to establish a scientific basis for resistance containment.
Principal Institution
Principal Investigators / Focal Persons
Partner Institutions
Partner Investigators
Rationale and Abstract
Malaria is one of the world’s three largest mosquito-borne infectious diseases. Artemisinin derivatives are the first-line drug for malaria, but applicants have confirmed that resistance has also emerged in Africa and has increased rapidly over the years. But it is unclear why that is happening. The results will enable the containment of resistance based on scientific evidence.
External reference
Themes
Date
Apr 2022 — Mar 2026
Total Project Funding
$145,484
Funding Details
Project Site
Related Resources
